1. Japanese encephalitis vaccines: moving away from the mouse brain.
- Author
-
Zanin MP, Webster DE, Martin JL, and Wesselingh SL
- Subjects
- Administration, Oral, Animals, Asia epidemiology, Australia epidemiology, Birds virology, Brain cytology, Brain virology, Cells, Cultured virology, Clinical Trials as Topic, Culicidae virology, Encephalitis, Japanese epidemiology, Encephalitis, Japanese veterinary, Evaluation Studies as Topic, Genetic Vectors genetics, Horse Diseases virology, Horses, Humans, Insect Vectors virology, Macaca, Mice, Poxviridae genetics, Poxviridae immunology, Recombinant Fusion Proteins immunology, Swine virology, Vaccines, Attenuated immunology, Vaccines, DNA immunology, Vaccines, Inactivated immunology, Viral Proteins immunology, Virion immunology, Virus Cultivation methods, Encephalitis Virus, Japanese immunology, Encephalitis, Japanese prevention & control, Japanese Encephalitis Vaccines isolation & purification
- Abstract
Japanese encephalitis (JE) is a severe disease that is widespread throughout Asia and is spreading beyond its traditional boundaries. Three vaccines are currently in use against JE but only one is available internationally, a mouse-brain-derived inactivated vaccine first used in the 1930s. Although this vaccine has been effective in reducing the incidence of JE, it is relatively expensive and has been linked to severe allergic and neurological reactions. Cell-culture-derived inactivated and attenuated vaccines have been developed but are only used in the People's Republic of China. Other vaccines currently in various stages of development are DNA vaccines, a chimeric yellow fever-JE viral vaccine, virus-like particle vaccines and poxvirus-based vaccines. Poxvirus-based vaccines and the chimeric yellow fever-JE vaccine have been tested in Phase I clinical trials. These new vaccines have the potential to significantly reduce the impact of JE in Asia, particularly if used in an oral vaccine delivery strategy.
- Published
- 2003
- Full Text
- View/download PDF